期刊文献+

聚乙二醇化重组人白细胞介素6的放射性标记 被引量:1

RADIO-LABELING OF POLYETHYLENE GLYCOL MODIFICATION OF RECOMBINANT HUMAN INTERLEUKIN-6
下载PDF
导出
摘要 分别用常规氯氨T和改进的双相氯氨T法对PEG-rhIL-6进行放射性碘标记,用柱层析法和离心超滤法对标记物分离纯化,同时用三氯乙酸沉淀法和SDS-PAGE电泳法鉴定纯化后的标记化合物放射化学纯度,采用rhIL-6依赖细胞7TD1,用MTT比色法测定标记物的生物学活性。结果表明:1.改进的双相氯氨T法标记率为74.5%,高于常规氯氨T法的62.3%,放射性比活度分别为5.513×105和4.610×105Bq/μg。2.经柱层析法和离心超滤法对标记物分离纯化后,用三氯乙酸沉淀法测得放射化学纯度均能达到99%以上。3.用SDS-PAGE电泳法检测两种标记方法所得的标记物与非标记物的结果表明,常规氯氨T法标记物比非标记物多1条高分子量蛋白带,认为是标记过程中蛋白质受到部分损伤;改进的双相氯氨T的标记物与非标记物蛋白质条带一致,认为蛋白质标记后基本没有受到损伤。4.生物活性检测表明改进的双相氯氨T标记物与非标记物活性之间无显著差异,常规氯氨T法标记物活性略低于双相氯氨T的标记物活性。 Iodine-125 was used as labeling nuclide, and the PEG-rhIL-6 was labeled by the common used chloramines-T and the two-phase chloramines-T, respectively. The labeled compound was purified by both methods of gel filtration and ultrafiltration respectively. The purity of the labeled PEG-rhIL-6 was determined by both trichloroacetic acid (TCA) and SDS- PAGE, and the biological activity was determined by MTr method. The results demonstrated that the labeling rate and specific radioactivity were 74.5% and 5.513 × 105 Bq/μg for PEG-rhIL-6 by the two-phase chloramines-T method, higher than that by the common used chloramines-T method, which was 62.3% and 4.610 × 105 Bq/μg respectively. The purity of labeled PEG- rhIL-6, purified by both gel filtration and ultrafiltration methods, was over 99 % with TCA method. The labeled PEG-rhIL-6 by two-phase chloramines-T method showed two bands, which was identical to that of standard PEG-rhIL-6 though SDS-PAGE, but the labeled PEG-rhIL-6 by common used chloramines-T method had one more band compared with standard PEG-rhIL-6. When determined by MTT, it shown that the biological activity of PEG-rhIL-6 iodinated by common used chloramines-T method was lower than that by two-phase chloramines-T method.
出处 《核农学报》 CAS CSCD 北大核心 2006年第3期236-240,共5页 Journal of Nuclear Agricultural Sciences
关键词 聚乙二醇化重组人白细胞介素-6 放射性碘标记 离心超滤法 MTT比色法 PEG-rhIL-6 chloramines-T radio-labeling TCA SDS-PAGE MTT
  • 相关文献

参考文献13

  • 1Hirano T,Akira S,Taga T,Kishimoto T.Biological and clinical aspects of interleukin 6.Immunol Today,1990,11 (12),443 ~ 449
  • 2王军志,李成明.白细胞介素-6的基础、临床研究及开发动向[J].中国生物制品学杂志,1997,10(3):187-190. 被引量:3
  • 3Tsutsumi Y,Tsunoda S,Kamada H,et al.PEGylation of interleukin-6effectively increases its thrombopoietic potency.Thromb Haemost,1997,77(1):168 ~ 173
  • 4Yasuo T,Tetsunari K,Shin-ichi T,et al.Polyethylene Glycol modification of interleukin-6 enhances its thrombopoietic activity.Journal of Control Release,1999,33,447 ~ 451
  • 5Inoue H,Kadoya T,Kabaya K,et al.A highly enhanced thrombopoietic activity by monomethoxy polyethylene glycol-modified recombinant human interleukin-6.J Lab Clin Med,1994,124(4):529 ~ 536
  • 6尹伯元.放射免疫测定基础[M].天津:天津科学出版社,1983.177-190.
  • 7刘国霞,曾宪垠,包伦,徐贤坤,陈志渝,刘显义.长效促红细胞生成素的放射性标记[J].核农学报,2004,18(1):55-58. 被引量:3
  • 8樊为民.碘标记化合物的质量指标及其鉴定方法[J].放射免疫学杂志,1996,9(1):51-54. 被引量:7
  • 9旺家政,范明.蛋白质技术手册.北京:科学出版社,2000
  • 10Bradford M M.A rapid and sensitive method for the qualification of microgram of protein utilizing the principle of protein-dye binding.Anal Biol,1975,72:248 ~ 254

二级参考文献16

  • 1徐懿群,何荣霞.联结法^(125)I标记癌钙蛋白[J].核技术,1996,19(5):309-313. 被引量:1
  • 2凌世淦,中华流行病学杂志,1992年,13卷,特2期,367页
  • 3任启生,中华流行病学杂志,1992年,13卷,特2期,371页
  • 4中国医学科学院首都核医学中心.NGF药代动力学实验研究:新药申报资料形式审查要点[Z].,.594-612.
  • 5Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biol. 1976. 72:248-254.
  • 6Tang Z.-M, Liu X. W, Xu L. P., et al. Pharmacokinetics and tissue distributian of human recombinant interleukin-2 in mice . Acta Pharmacol Sin, 1994, 15 (1): 51-55.
  • 7Salacinski P. R., McLean C., Sykes J. E. C., et al. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (Iodogen) . Anal Biochem, 1981, 117:136~146.
  • 8Yanagawa S.-i, Hirade K., Ohnota H., Snsaki R. ,et al. Isolation of human erythropoietin with monoclonal antibodies. J Biol Chem, 1984, 259:2707-2710.
  • 9Miyake T, Kung C K-H, Goldwssser E. Purification of hunam erythropoietin. J Bio Chem, 1977, 252:5558-5564.
  • 10Tejedor F., Ballesta J.P.G. Iodination of biological samples without loss of functional activity . Anal Biochem, 1982, 127:143-149.

共引文献37

同被引文献17

  • 1朱小华,吴华.多肽的放射性标记[J].放射学实践,2004,19(11):850-852. 被引量:2
  • 2魏莉,罗荣城.放射性核素标记抗CD20单克隆抗体治疗B细胞淋巴瘤的研究进展[J].国际放射医学核医学杂志,2006,30(3):153-157. 被引量:5
  • 3Radiolabelled proteins for positron emission tomography:Pros and cons of labeling methods.Biochim Biophys Acta,2010,1800(5):487.
  • 4Riederer B M.Non-covalent and covalent protein labeling intwo-dimensional gel electrophoresis.J Proteomics,2008,71(2):231.
  • 5Tijink BM,Perk LR,Budde M,et al.124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy,Eur J Nucl Med Mol Imaging,2009,36(8):1235.
  • 6Tolmachev V,Orlova A,Lundqvist H,et al.Optimization of iodination of[^125I]-Nsuccinimidyl-para-iodobenzoate using Chloramine-T for labelling of proteins.J Radioanal Nucl Chem,2000,246(1):207.
  • 7Jennewein M,Hermanne A,Mason RP,et al.A new method for the labelling of proteins with radioactive arsenic isotopes[J].Nucl Instrum Methods in Phys Res,Sect A.2006,569(2):512.
  • 8Jennewein M,Lewis MA,Zhao D,et al.Vascular Imaging of SolidTumors in Ratswith a RadioactiveArsenic-Labeled Antibody that Binds Exposed Phosphatidylserine.Clin Cancer Res,2008,14(5):1377.
  • 9Wunderlich G,Drews A,Kotzerke J,et al.A kit for labeling of[^188Re] human serum albuminmicrospheres for therapeutic use in nuclear medicine[J].Appl Radiat Isot,2005,62(6):915.
  • 10Andrus MB,Turner TM,Sauna ZE,et al.Synthesis and Preliminary Analysis of a P-Glycoprotein-Specific[^3H]-Benzophenone Photoaffinity Label Based on (-)-Stipiamide[J].Bioorg Med Chem Lett,2000,10(20):2275.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部